Revvity (RVTY) Short-term Investments (2023 - 2024)
Revvity's (RVTY) quarterly Short-term Investments came in at $706.1 million in Q2 2024, down 4.46% YoY from $739.1 million in Q3 2023, and up 1.25% on a QoQ basis from $697.3 million in Q1 2024.
Revvity (RVTY) Short-term Investments (2023 - 2024) Analysis & Trends
Revvity (RVTY) has 2 years of Short-term Investments data on file, last reported at $706.1 million in Q2 2024.
- Quarterly Short-term Investments fell 4.46% year-over-year to $706.1 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $706.1 million (down 4.46% YoY) and the FY2023 annual result came in at $689.9 million, changed N/A from the prior year.
- Short-term Investments rose to $706.1 million in Q2 2024, from $697.3 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $739.1 million in Q3 2023 to a low of $194.0 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 706.07 Mn |
| Mar 31, 2024 | 697.33 Mn |
| Dec 31, 2023 | 689.92 Mn |
| Oct 1, 2023 | 292.97 Mn |
| Jul 2, 2023 | 739.06 Mn |
| Apr 2, 2023 | 193.96 Mn |